top of page

Investment opportunities now available

Opportunity to become a category leader in patient monitoring

Treating kidney disease costs over $120B a year
$2B a week spent by US Medicare alone

Value-based providers are seizing the initiative – and market share
Rapid, venture-backed growth wi
th 10% of kidney patients now in value-based care

Improved outcomes start with a patient-centric approach
Providers & patients need better data & tools to lower health risks & enable new treatments


Download corporate summary

Download a summary here.

Request investor presentation


Request sent

Backed by life sciences investors

At Kalium Health we welcome investors who share our vision of expanding patient access while driving down the cost of long-term disease management.


We partner with investors who:

  • Recognise the challenges and opportunities in healthcare innovation

  • Enjoy deep-diving into our novel, world-class technology 

  • Are well-placed to support us through international commercialisation and rapid company growth

We benefit from strong support from our current investors including the University of Cambridge, Martlet Capital, Kidney Research UK, Jonathan Milner and experienced business angels.

Kalium Health in the media


Fierce Healthcare

Chutes & Ladders–Major retail players hire new leaders

Med-Tech Innovation News

Cambridge spinout advances towards clinical evaluation after R&D success

The Engineer

Kalium Health developing world’s first at-home blood potassium test

Royal Society of Chemistry Sensors & Diagnostics Journal

Point-of-care and self-testing for potassium: recent advances

OBN Network

Kalium shortlisted for 2023 OBN Award

See our News page for all our latest news

bottom of page